Late mortality and levamisole adjuvant therapy in colorectal cancer.

[1]  D. Longo,et al.  Dose-related immunologic effects of levamisole in patients with cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  B. Scheithauer,et al.  Multifocal inflammatory leukoencephalopathy with 5‐fluorouracil and levamisole , 1992, Annals of neurology.

[3]  Earlybreastcancertrialistscol,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992, The Lancet.

[4]  D. Parkinson,et al.  Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Broadhead,et al.  WHO consensus statement. , 1990, The British journal of psychiatry : the journal of mental science.

[6]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[7]  Adjuvant therapy for patients with colon and rectum cancer. , 1990, Consensus statement. National Institutes of Health Consensus Development Conference.

[8]  T. Fleming,et al.  Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Buyse,et al.  Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double‐blind randomized clinical trial , 1989, The British journal of surgery.

[10]  R. Chlebowski,et al.  Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial. , 1988, Oncology.

[11]  P. Bell,et al.  Five year results of a randomized trial of adjuvant 5‐fluorouracil and levamisole in colorectal cancer , 1987, The British journal of surgery.

[12]  W. van Putten,et al.  Levamisole as adjuvant immunotherapy in breast cancer , 1987, Cancer.

[13]  A. Rubagotti,et al.  Adjuvant immunochemotherapy in colorectal cancer Dukes C. , 1987, Oncology.

[14]  Executivecommitteeofthedanish.  INCREASED BREAST-CANCER RECURRENCE RATE AFTER ADJUVANT THERAPY WITH LEVAMISOLE A Preliminary Report , 1980 .

[15]  C. McArdle,et al.  Adjuvant Chemotherapy and Immunotherapy for Colorectal Cancer: Preliminary Communication 1 , 1980, Journal of the Royal Society of Medicine.

[16]  D. Scott,et al.  Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure. , 1979, Thorax.